Filtered By:
Condition: Heart Attack
Infectious Disease: Helicobacter Pylori

This page shows you your search results in order of relevance.

Order by Relevance | Date

Total 9 results found since Jan 2013.

Carotid intima media thickness and blood biomarkers of atherosclerosis in patients after stroke or myocardial infarction.
CONCLUSIONS: Our study supports linear correlations between CIMT and IC and hs-CRP levels. However, these associations seem to depend on the type of vascular burden. PMID: 28051279 [PubMed - in process]
Source: Croatian Medical Journal - December 30, 2016 Category: Journals (General) Authors: Kurkowska-Jastrzebska I, Karlinski MA, Błazejewska-Hyzorek B, Sarzynska-Dlugosz I, Filipiak KJ, Czlonkowska A Tags: Croat Med J Source Type: research

The combination of Helicobacter pylori- and cytotoxin-associated gene-A seropositivity in relation to the risk of myocardial infarction in middle-aged Japanese: The Japan Public Health Center-based study
Conclusions: H. pylori infection was not significantly associated with risk of MI and stroke among middle-aged Japanese. However, CagA positivity tended to be associated with MI.Highlights:
Source: Atherosclerosis - August 20, 2013 Category: Cardiology Authors: Ai Ikeda, Hiroyasu Iso, Shizuka Sasazuki, Manami Inoue, Shoichiro Tsugane, for the JPHC Study Group Tags: Clinical & Population Research - Epidemiology, Biomarkers, Nutrition Source Type: research

Anticardiolipin Antibodies in Children with Helicobacter pylori Infection
ConclusionsIn our particular experience, H. pylori can cause aCL antibody positivity in children and eradication of H. pylori provides the disappearance of these antibodies.
Source: Helicobacter - April 1, 2015 Category: Gastroenterology Authors: Serdar Umit Sarıcı, Orhan Gursel, Emin Kurekci, Vural Kesik, Avni Atay, Vedat Okutan, Ali Inal, Aysel Pekel, Mehmet Ali Ozguven, Okan Ozcan Tags: Original Article Source Type: research

What Your Blood Type Means For Your Health
ImageContent(5627c16ae4b08589ef4a227d,5627c0981400006f003c8c87,Image,HectorAssetUrl(5627c0981400006f003c8c87,Some(crop_29_110_3211_2335),Some(jpeg)),AlexRaths via Getty Images,) EmbedContent(5627c16ae4b08589ef4a227e,SPECIAL FROM ,Embed,html,Some({})) Quick: What’s your blood type? If you’re scratching your head, you may be missing out on an important health clue. A spate of recent research suggests that your blood type—whether A, B, AB, or O—may influence your risk for a variety of health conditions, from cardiac disease to cancer.   The research is still early and scientists aren’t yet s...
Source: Healthy Living - The Huffington Post - October 25, 2015 Category: Consumer Health News Source Type: news

Metabolic consequences of Helicobacter pylori infection and eradication.
Abstract Helicobacter pylori (H. pylori) is still the most prevalent infection of the world. Colonization of the stomach by this agent will invariably induce chronic gastritis which is a low-grade inflammatory state leading to local complications (peptic ulcer, gastric cancer, lymphoma) and remote manifestations. While H. pylori does not enter circulation, these extragastric manifestations are probably mediated by the cytokines and acute phase proteins produced by the inflammed mucosa. The epidemiologic link between the H. pylori infection and metabolic changes is inconstant and controversial. Growth delay was des...
Source: World Journal of Gastroenterology : WJG - May 14, 2014 Category: Gastroenterology Authors: Buzás GM Tags: World J Gastroenterol Source Type: research

Estimates of benefits and harms of prophylactic use of aspirin in the general population
Conclusions Prophylactic aspirin use for a minimum of 5 years at doses between 75 and 325 mg/day appears to have favourable benefit–harm profile; longer use is likely to have greater benefits. Further research is needed to determine the optimum dose and duration of use, to identify individuals at increased risk of bleeding, and to test effectiveness of Helicobacter pylori screening–eradication before starting aspirin prophylaxis.
Source: Annals of Oncology - December 17, 2014 Category: Cancer & Oncology Authors: Cuzick, J., Thorat, M. A., Bosetti, C., Brown, P. H., Burn, J., Cook, N. R., Ford, L. G., Jacobs, E. J., Jankowski, J. A., La Vecchia, C., Law, M., Meyskens, F., Rothwell, P. M., Senn, H. J., Umar, A. Tags: reviews Source Type: research

Evaluation of the risk of cardiovascular events with clarithromycin using both propensity score and self‐controlled study designs.
ConclusionsThere was some evidence for a short term association for first MI but none for a long term association for any outcome.
Source: British Journal of Clinical Pharmacology - April 19, 2016 Category: Drugs & Pharmacology Authors: Adrian A. Root, Angel Y. S. Wong, Yonas Ghebremichael‐Weldeselassie, Liam Smeeth, Krishnan Bhaskaran, Stephen J. W. Evans, Ruth Brauer, Ian Chi Kei Wong, Vidya Navaratnam, Ian Douglas Tags: Pharmacoepidemiology Source Type: research

Infection and atherosclerosis: TLR-dependent pathways.
This article reviews the role of TLRs in the process of atherosclerosis after C. pneumoniae and other infections and the current status of treatment, with a view to providing a new direction and potential therapeutic targets for the study of ASVD. PMID: 32002588 [PubMed - as supplied by publisher]
Source: Cellular and Molecular Life Sciences : CMLS - January 29, 2020 Category: Cytology Authors: Li B, Xia Y, Hu B Tags: Cell Mol Life Sci Source Type: research